Evidence map›Paper›PMID 17139332›Full record

ReviewNature reviews. Molecular cell biology2006

Editor meets silencer: crosstalk between RNA editing and RNA interference.

Kazuko Nishikura

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Molecular cell biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 163 papers.

0numbers the graph read from it
0cells of the map it votes in
163citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

163 citing papers in PubMed, 282 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. MiREDiBase: A Comprehensive Resource for miRNA Editing Events.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Review
  6. Review
  7. Promiscuous RNA editing in lncRNARNA (New York, N.Y.) · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Saudi journal of biological sciences · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

103 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Kazuko NishikuraThe Wistar Institute, Department of Gene Expression and Regulation, 3601 Spruce Street, Philadelphia, Pennsylvania 19104-4268, USA. kazuko@wistar.org
The Wistar Institute · US

Funding

VAV ANTISENSE ODN--A NOVEL THERAPEUTIC FOR HUMAN LEUKEMIASP01CA072765 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GEWIRTZ, ALAN M · 1997 to 2007
$8.5M
STRUCTURE AND FUNCTION OF DSRNA ADENOSINE DEAMINASER01GM040536 · NIGMS · WISTAR INSTITUTE · PI NISHIKURA, KAZUKO · 1991 to 2021
$8.1M
Functions of ADARI RNA Editase in ErythropoiesisR01HL070045 · NHLBI · WISTAR INSTITUTE · PI NISHIKURA, KAZUKO · 2002 to 2005
$1.7M
NCI NIH HHS P01 CA072765NHLBI NIH HHS R01 HL070045NIGMS NIH HHS R01 GM040536
6 · The paper itself

Abstract

The most prevalent type of RNA editing is mediated by ADAR (adenosine deaminase acting on RNA) enzymes, which convert adenosines to inosines (a process known as A-->I RNA editing) in double-stranded (ds)RNA substrates. A-->I RNA editing was long thought to affect only selected transcripts by altering the proteins they encode. However, genome-wide screening has revealed numerous editing sites within inverted Alu repeats in introns and untranslated regions. Also, recent evidence indicates that A-->I RNA editing crosstalks with RNA-interference pathways, which, like A-->I RNA editing, involve dsRNAs. A-->I RNA editing therefore seems to have additional functions, including the regulation of retrotransposons and gene silencing, which adds a new urgency to the challenges of fully understanding ADAR functions.

Indexed as

RNA EditingRNA InterferenceAdenosineAdenosine DeaminaseAlu ElementsAnimalsGene Expression RegulationHumansInosineIntronsRetroelementsRNA-Binding ProteinsRNA, Double-StrandedRNA, Small InterferingADARB1 protein, humanAdenosineAdenosine DeaminaseInosineRetroelementsRNA-Binding ProteinsRNA, Double-StrandedRNA, Small Interfering

Identifiers

PMID17139332
PMCPMC2953463
OpenAlexW2063538505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.